Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-1 in Chemotherapy-Naïve Advanced Pancreatic Cancer
NCT00651742Phase 2Completed
- Sponsor
- Taiho Oncology
- Start
- Jan 2006
- Primary completion
- Jul 2008
- Modality
- Small Molecules
01
Overview
Phase 2, open-label, single-arm trial of tegafur in pancreatic cancer (PC), sponsored by Taiho Oncology. Primary endpoint: Overall Tumor Response Rate. Started Jan 2006; status: completed.
02
Drugs
tegafur
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00651742.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00651742.